Consultants Forum Advertise
Subscribe
Close

  • Free for qualified executives and consultants to industry

  • Receive quarterly issues of Area Development Magazine and special market report and directory issues

Subscribe Now
Renew

Area Development - Site Selection, Facility Planning and Workforce Development

Phillips-Medisize Expands Menomonie, Wisconsin Manufacturing Complex

01/09/2017
Phillips-Medisize, a global leader in outsource design, development and technology-driven manufacturing, plans to grow significantly at its campus in Menomonie, Wisconsin. The company is in the process of building an 80,000 square foot, state-of-the-art facility that is estimated to employ more than 100 people within the next three to five years.

“This facility will add to our manufacturing capacity to produce fully assembled and packaged drug delivery devices,” said Matt Jennings, CEO & President of Phillips-Medisize, a Molex company. “We are proud of our leading-edge manufacturing campus in Menomonie and remain dedicated to investing in our people and facilities in the area. This is the third expansion to our Menomonie campus this year.”

“Staff Management | SMX is looking forward to the completion of Phillips-Medisize’s newest facility so we can continue to connect members of the Menomonie community with work,” said Jonathan Means, President of Staff Management | SMX. "We are continuously impressed with the hard work and dedication of our Phillips-Medisize associates.” said staff management.

Phillips-Medisize is a global outsource provider of design and manufacturing services to the drug delivery and combination products, consumable diagnostics and medical device, and specialty commercial markets. The company has annual sales of over $700 million with 80% of the total revenue coming from drug delivery, medical device, primary pharmaceutical packaging and diagnostic products such as: disposable insulin pens, glucose meters, specialty inhalation drug delivery devices, single use surgical devices and consumable diagnostic components.

Exclusive Research